Events Search and Views Navigation
The 52nd Annual Meeting of the International Society for Developmental Psychobiology (ISDP) will be held October 16-18, 2019, at the Swissôtel Chicago, as a Satellite Meeting of the Society for Neuroscience. Researchers interested in the development of behavior in all organisms including man, with special attention to the effects of biological factors operating at any level of organization are encouraged to participate. Abstracts for oral or poster presentation of research results and theory in the area of Developmental Psychobiology as well as student/postdoc travel award applications should be submitted by June 1, 2019. The ISDP strongly supports and encourages young scientists with travel awards, networking and meeting events designed specifically for the students and postdocs in the field.
The ISDP 2019 Meeting hotel is conveniently located on the Society for Neuroscience hotel shuttle route.Find out more »
The world’s most important conference on basic, translational and clinical research related to cytokine biology
Cytokines & Interferons: From Biology to Clinics
Cytokine targeting has become one of the greatest revolutions in modern medicine. A large number of severe and sometimes even lethal inflammatory and autoimmune diseases have become manageable due to selective inhibition of cytokines and cytokine signaling. The development of compounds that selectively inhibit cytokines or interferons has permitted an so far unprecedented molecular characterization of human disease. Cytokines also contribute to cancer development and alterations in tissue homeostasis. Cytokines 2019 will address these developments and provide a comprehensive picture of the current knowledge of cytokine pathways in human disease and the strategies to inhibit, modulate or foster cytokine responses.Find out more »
The program follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment and survival.
With more detailed understanding of the genomic and molecular characteristics of cancer, we are closer towards the practice of precision medicine with tailored approaches to individual patient or groups of patients. It is our plan to address these issues in detail with the goal to bring basic scientists, oncologists, surgeons and radiologists from around the world together to allow cross-fertilization of ideas resulting in the translation of basic science into clinical application and challenging basic scientists with clinical issues. We hope that with advancements in cancer biology, treatment and care, cancer survivors may live longer and enjoy an improved quality of life than before.Find out more »